Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lessened its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 1.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 224,176 shares of the company's stock after selling 3,033 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.24% of Addus HomeCare worth $28,100,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wasatch Advisors LP raised its stake in shares of Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock valued at $138,782,000 after purchasing an additional 110,010 shares in the last quarter. TimesSquare Capital Management LLC raised its stake in Addus HomeCare by 28.5% during the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after buying an additional 78,835 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after buying an additional 75,409 shares during the last quarter. Barclays PLC lifted its holdings in Addus HomeCare by 204.8% during the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock worth $5,783,000 after buying an additional 29,207 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Addus HomeCare by 7.1% in the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company's stock worth $56,406,000 after acquiring an additional 28,284 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insiders Place Their Bets

In other news, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Stock Down 1.1 %

ADUS stock traded down $0.97 during trading on Friday, reaching $89.93. 209,905 shares of the company's stock were exchanged, compared to its average volume of 148,686. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72. The firm has a market cap of $1.63 billion, a PE ratio of 20.58, a P/E/G ratio of 1.41 and a beta of 0.97. The company's fifty day moving average price is $112.54 and its 200-day moving average price is $122.17.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, sell-side analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ADUS has been the topic of several research analyst reports. Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. Macquarie restated an "outperform" rating and issued a $129.00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an "outperform" rating and a $150.00 target price on the stock. Finally, Stephens reaffirmed an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $132.78.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.